Risk of impairment losses due to deteriorating profitability of business assets
First written in FY2016. 5 of 8 entries say "Materialised", first in FY2016. Latest entry: FY2025-H1.
The whole theme swung hardest in 2026: 67 of 129 companies on the "Worse" side.
- FY2025-H1MaterialisedAnnual report
「During the current interim consolidated accounting period, our Group recognised impairment losses on the following asset groups.」
An impairment loss of ¥118 million was recognised on construction in progress for high-potency injectable manufacturing equipment, providing an additional instance of the impairment risk caused by declining profitability of operating assets materialising. - FY2024WorsenedAnnual report
「The start of operations at the high-potency injectable manufacturing equipment was delayed from the original plan. … The carrying amounts of these assets were reduced to their recoverable value, and the resulting reduction of ¥4,093,056 thousand was recognised as an impairment loss.」
The timing of orders for major contract projects involving the high-potency injectable manufacturing equipment was substantially delayed, resulting in an impairment loss of ¥4,093,056 thousand. - FY2022MaterialisedAnnual report
「Impairment loss 36,201」
An impairment loss of ¥36,201 thousand was recognised in the fine chemicals business during the current consolidated fiscal year. - FY2020MitigatedAnnual report
「Current consolidated fiscal year (from 1 December 2019 to 30 November 2019) Impairment loss 5,960」
The impairment loss decreased from ¥15,988 thousand in the previous fiscal year to ¥5,960 thousand, but the chemicals business continued to recognise impairment losses. - FY2019MaterialisedAnnual report
「Current consolidated fiscal year (from 1 December 2018 to 30 November 2019) Impairment loss 15,988」
The chemicals business recognised an impairment loss of ¥15,988 thousand, meaning that the impairment risk caused by deteriorating profitability of operating assets materialised again. - FY2018MaterialisedAnnual report
「(Unit: ¥ thousand) Pharmaceuticals / FC HBC Chemicals Food Other Adjustments Total Impairment loss — — 8,004 — — — 8,004」
An impairment loss of ¥8,004 thousand was actually recognised in the chemicals business during the current consolidated fiscal year. - FY2017RestatedAnnual report
「Our Group holds various assets used in its businesses, including manufacturing equipment. If their fair value declines significantly, or if the profitability of operating assets deteriorates and a recovery is not expected, the application of impairment accounting and the resulting recognition of impairment losses on those fixed assets could affect the performance of our Group.」
The impairment risk itself continues to be disclosed, but no impairment loss was recognised for the current consolidated fiscal year. - FY2016MaterialisedAnnual report
「If the profitability of operating assets deteriorates and a recovery is not expected, the application of impairment accounting and the resulting recognition of impairment losses on those fixed assets could affect the performance of our Group.」
The Company recognised an impairment loss of ¥1,043,882 thousand on certain operating assets in its chemicals business due to deteriorating operating income and the absence of prospects for a short-term recovery.